perioperative management of glp-1 agonists How should we approach patients on #GLP1 agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Patients on Glucagon-Like Perioperative Management of GLP-1 RAs

However, a retrospective cohort study of electronic health records involving 240,618 patients with overweight or obesity prescribed semaglutide or non-GLP-1 receptor agonist antiobesity medications, and 1,589,855 patients with type 2 diabetes prescribed semaglutide or other hypoglycaemic agents, found a lower risk of suicidal ideation in patients prescribed semaglutide regardless of prior psychiatric history

PubMed Conclusion GHK-Cu copper peptide serums are a scientifically grounded approach to combating hair thinning

Many of these drugs havent done CVD trials yet, said Mithal

This is exactly why I created my Fatigue and Brain Fog Fix in Six (Thyroid and Adrenal Edition) program , and why I wrote my book, Adrenal Transformation Protocol , which takes readers through my tried and true process to transform their adrenals in just four weeks

Egashira R, Matsunaga M, Miyake A, Hotta S, Nagai N, Yamaguchi C, et al

Safety Profile and Adverse Event Considerations Tesamorelin's most common adverse effects include injection-site reactions, arthralgias, carpal tunnel syndrome, and glucose abnormalities in some patients